Systemic mitochondrial dysfunction and the etiology of Alzheimer's disease and down syndrome dementia

Topic: Genetics and APOE

Increasing evidence is implicating mitochondrial dysfunction as a central factor in the etiology of Alzheimer's disease (AD). The most significant risk factor in AD is advanced age and an important neuropathological correlate of AD is the deposition of amyloid-beta peptide (Abeta40 and Abeta42) in the brain. An AD-like dementia is also common in older individuals with Down syndrome (DS), though with a much earlier onset. We have shown that somatic mitochondrial DNA (mtDNA) control region (CR) mutations accumulate with age in post-mitotic tissues including the brain and that the level of mtDNA mutations is markedly elevated in the brains of AD patients. The elevated mtDNA CR mutations in AD brains are associated with a reduction in the mtDNA copy number and in the mtDNA L-strand transcript levels. We now show that mtDNA CR mutations increase with age in control brains; that they are markedly elevated in the brains of AD and DS and dementia (DSAD) patients; and that the increased mtDNA CR mutation rate in DSAD brains is associated with reduced mtDNA copy number and L-strand transcripts. The increased mtDNA CR mutation rate is also seen in peripheral blood DNA and in lymphoblastoid cell DNAs of AD and DSAD patients, and distinctive somatic mtDNA mutations, often at high heteroplasmy levels, are seen in AD and DSAD brain and blood cells DNA. In aging, DS, and DSAD, the mtDNA mutation level is positively correlated with beta-secretase activity and mtDNA copy number is inversely correlated with insoluble Abeta40 and Abeta42 levels. Therefore, mtDNA alterations may be responsible for both age-related dementia and the associated neuropathological changes observed in AD and DSAD.

@article{coskun2010-20463402,
  author  = {Coskun, P. E. and Wyrembak, J. and Derbereva, O. and Melkonian, G. and Doran, E. and Lott, I. T. and Head, E. and Cotman, C. W. and others},
  title   = {{Systemic mitochondrial dysfunction and the etiology of Alzheimer's disease and down syndrome dementia}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2010},
  doi     = {10.3233/jad-2010-100351},
  pmid    = {20463402},
  url     = {https://doi.org/10.3233/jad-2010-100351}
}

Key findings

• The most significant risk factor in AD is advanced age and an important neuropathological correlate of AD is the deposition of amyloid-beta peptide (Abeta40 and Abeta42) in the brain.
• We have shown that somatic mitochondrial DNA (mtDNA) control region (CR) mutations accumulate with age in post-mitotic tissues including the brain and that the level of mtDNA mutations is markedly elevated in the brains of AD patients.
• The elevated mtDNA CR mutations in AD brains are associated with a reduction in the mtDNA copy number and in the mtDNA L-strand transcript levels.
• We now show that mtDNA CR mutations increase with age in control brains; that they are markedly elevated in the brains of AD and DS and dementia (DSAD) patients; and that the increased mtDNA CR mutation rate in DSAD brains is associated with reduced mtDNA copy number and L-strand transcripts.

Study details

• Evidence strengthLow

Read the original

• DOI: 10.3233/jad-2010-100351
• PubMed: 20463402
• Original source →

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Related studies in Down syndrome and Alzheimer's

• A mitochondrial etiology of Alzheimer and Parkinson disease Biochimica et biophysica acta · 2011-08-16 · usefulness score 47/100
• Oxidative stress and mitochondrial dysfunction in Down syndrome Advances in experimental medicine and biology · 2012-01-01 · usefulness score 41/100
• Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets Molecular medicine (Cambridge, Mass.) · 2018-03-15 · usefulness score 41/100
• Therapeutics for mitochondrial dysfunction-linked diseases in Down syndrome Mitochondrion · 2022-11-09 · usefulness score 35/100
• Mitochondrial Dysfunction, Oxidative Stress, and Neuroinflammation: Intertwined Roads to Neurodegeneration Antioxidants (Basel, Switzerland) · 2020-07-22 · usefulness score 41/100
• Insulin resistance, oxidative stress and mitochondrial defects in Ts65dn mice brain: A harmful synergistic path in down syndrome Free radical biology & medicine · 2021-01-29 · usefulness score 43/100

Also tagged “dosage”

80 studies in the library carry the topic tag “dosage”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 80 tagged studies.

• Down's syndrome Lancet (London, England) · 2003-04-01 · usefulness score 41/100 · Risk factors
• Changes in mortality and causes of death in the Swedish Down syndrome population American journal of medical genetics. Part A · 2013-02-22 · usefulness score 36/100 · Down syndrome and Alzheimer's
• Prevalence of epilepsy and young-onset dementia in adults with intellectual disability: Contrasting Down syndrome and autism diagnoses PsyArXiv · 2026-06-15 · usefulness score 16/100 · Costs and economics

Similar studies

• The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives 2014 · Risk genes beyond APOE
• Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease 1994 · Disease mechanisms
• Mitochondria and Mitochondrial Cascades in Alzheimer's Disease 2018 · Disease mechanisms
• Mitochondrial abnormalities in Alzheimer's disease 2001 · Disease mechanisms
• Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease 2008 · Risk genes beyond APOE
• Mitochondrial DNA affects tau phosphorylation in aging and Alzheimer's disease 2025 · Biomarkers

More on Down syndrome and Alzheimer's

• A review that covers this ground Mitochondrial Imbalance in Down Syndrome: A Driver of Accelerated Brain Aging? Aging and disease · 2025-04-06 · usefulness score 36/100
• Newest in this subject Differential endothelial cell remodeling in Down syndrome and APP duplication drives distinct blood brain barrier dysfunction bioRxiv · 2026-10-30 · Preprint — not yet peer-reviewed · usefulness score 16/100
• Newest in this subject Memory and Plasma pTau217 Refine Prognosis in Down Syndrome Annals of neurology · 2026-10-02 · Peer-reviewed · usefulness score 47/100

See all studies in Down syndrome and Alzheimer's →